Cannabis Stocks Surge on Trump Video Global cannabis stocks have enjoyed a considerable, but likely temporary, run this week, after US President Donald Trump shared a video apparently endorsing the use of CBD for senior healthcare.
Amid rising global scrutiny of the wider medical cannabis prescription model, and with markets like France leaning into pharmaceutical-grade regulation, the pharma cannabis sector is shaping up to be one of the most dynamic and closely watched corners of the industry.
The US cannabis rescheduling project, which has been stuck in limbo since being ‘temporarily’ shelved six months ago, is now facing another existential threat from the government’s wide reaching budget.
The Trump administration’s ‘One Big Beautiful Bill’, the federal government’s annual spending and tax omnibus legislation, has quietly dropped a key piece of legislation putting the country’s entire medical cannabis industry under threat.
The shock announcement this week that a federal trade court had ruled that key elements of President Trump’s flagship tariff policy were unconstitutional has come as a major relief for any internationally-facing US business, not least the cannabis sector.
The US Cannabis Roundtable (USCR), one of the most influential advocacy groups in the country, is ‘still optimistic about the President acting on cannabis reform’.
Licensed cannabis operators and ancillary companies are bracing for rising business costs, lost customers and vendor backlash in the wake of President Donald Trump’s erratic blanket tariffs that have rattled the global economy and stoked fears of a recession and accelerated inflation in the United States.
The incomprehensible economic strategy of President Trump’s global tariffs has left almost every US industry scratching their heads, and fearing for the future.
‘Liberation day’, set to take place on April 02, has been pitched as the day the Trump administration will roll out sweeping and aggressive tariffs for all of the US’ trading partners.
